100 Views

Session: Colorectal Great Debate: Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Total Neoadjuvant Therapy Represents Overtreatment and Should Be Used Selectively for Locally Advanced (T3/4 or N+) Rectal Cancer (Con)

Thursday, March 10, 2022

3:35 PM – 3:50 PM CST

Location: Trinity Ballroom

Debater(s)

Julio Garcia-Aguilar, MD, PhD

Chief Attending
Memorial Sloan Kettering Cancer Center
New York, NY, United States

Disclosure: Ethicon J&J (Individual(s) Involved: Self): Speaker/Honoraria; Intuitive Surgical (Individual(s) Involved: Self): Consultant, Speaker/Honoraria, Stockholder; Medtronic (Individual(s) Involved: Self): Consultant

Participants should be aware of the following financial/non-financial relationships:

Julio Garcia-Aguilar, MD, PhD: Ethicon J&J (Individual(s) Involved: Self): Speaker/Honoraria; Intuitive Surgical (Individual(s) Involved: Self): Consultant, Speaker/Honoraria, Stockholder; Medtronic (Individual(s) Involved: Self): Consultant